Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry
Completed
- Conditions
- Coronary VasospasmCardiac Death
- Registration Number
- NCT02298543
- Lead Sponsor
- Seung-Jung Park
- Brief Summary
The purpose of this study is to evaluate the natural course of coronary spasm patients presenting aborted sudden cardiac death and analyze risk factors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Age 18 and more
- Coronary spasm
Exclusion Criteria
- Life expectancy less than 2years
- Coronary stenosis 50% and more
- Structural abnormalities of the heart leading to ventricular arrhythmia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ventricular tachycardia 1 year all cause death 1 year ventricular Fibrillation 1 year myocardial infarction 1 year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie coronary spasm in aborted sudden cardiac death patients?
How do calcium channel blockers compare to nitrates in managing coronary vasospasm post-aborted cardiac arrest?
Which biomarkers correlate with risk stratification in NCT02298543 coronary spasm registry?
What adverse events are associated with long-term follow-up of coronary spasm survivors in observational studies?
Are there novel therapeutic targets for coronary vasospasm beyond Rho-kinase inhibition in sudden cardiac death prevention?
Trial Locations
- Locations (1)
Asan Medical Center
🇰🇷Seoul, Songpa-gu, Korea, Republic of
Asan Medical Center🇰🇷Seoul, Songpa-gu, Korea, Republic of